CRISPR technology allows for precise DNA modifications, holding promise for treating genetic disorders and revolutionizing ...

Editas is partnering its CRISPR platform with Genevant’s LNP technology to develop novel gene editing medicines in a deal ...

在生物学的世界里，基因编辑技术一直是科学家探索的热门领域，近年来，CRISPR-Cas系统的发现和研究为基因编辑带来了革命性的变化。CRISPR-Cas系统为原核生物提供了RNA引导的适应性免疫应答，以抵御入侵的可移动基因元件，如病毒基因组、外源质粒 ...

An editorial by Fyodor Urnov lays out the urgent case for major reform in the regulatory appraisal of clinical therapies involving CRISPR gene therapies.

Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.

The technology’s promise can sound like science fiction—it might help us adapt to a radically different climate, or grow ...

Recent scientific breakthroughs have significantly enhanced our knowledge of genetics and ancient organisms. Technological ...

New research demonstrates the potential of precise genome editing technologies, called adenine base editors, to correct disease-causing mutations in stem cells from patients with X-linked chronic ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $48.51, marking a -0.84% move from the previous day. This change lagged the S&P 500's daily loss of 0.18%. Elsewhere, the Dow saw ...

Lipid nanoparticles deliver CRISPR tools directly to lung stem cells, offering new therapeutic avenues for treating genetic ...